SP1 Formula NDC 61077-101

NDC codes

FDA NDC Directory

Product NDC (as listed)61077-101Labeler and product segments. Claims need a package NDC.

Product NDC at billing width61077-0101Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
61077-101-11	61077010111	11 mL in 1 BOTTLE, DROPPER (61077-101-11)Marketed from Nov 6, 2013
61077-101-33	61077010133	33 mL in 1 BOTTLE, DROPPER (61077-101-33)Marketed from Nov 6, 2013

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): SP1 Formula
Generic name (nonproprietary): phytolacca decandra, thuja occidentalis
Active ingredients: Phytolacca americana root — 15 [hp_C]/11mLThuja occidentalis leafy twig — 15 [hp_C]/11mL
Dosage form: Oil
Route: Topical
Labeler: Healing Natural Oils LLC
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Nov 6, 2013
Listing expires: Dec 31, 2026
Identifiers: Product ID 61077-101_c1e07d15-a070-4f94-ac02-de36b19f2374SPL ID c1e07d15-a070-4f94-ac02-de36b19f2374SPL set ID 92bbd4b2-7945-4661-90b2-02538dbe2910UNII 11E6VI8VEG, 1NT28V9397

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N461077010111 followed by a unit qualifier and the quantity

Package 61077-0101-11. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 27, 2017.

Indications (excerpt from the label)

Indications: For the treatment of wart symptoms associated with common warts (cauliflower like appearance), plantar warts (under the feet) and flat warts.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)